Apollo Oral Insulin Update - Phase 1 Toxicology Trials For Oral Insulin And Its Oral Delivery Device, Oradel

... Apollo Life Sciences (ASX:AOP) today announced the successful completion of data collection in independent Phase 1 toxicology trials for oral insulin and its oral delivery device, Oradel. No significant adverse events were reported during the two-species trial to test the safety of Apollo's drug candidate for people with diabetes. [click link for full article] ...